Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 14:17:40 UTC |
---|
Update Date | 2023-02-21 17:16:14 UTC |
---|
HMDB ID | HMDB0002182 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Phenylephrine |
---|
Description | Phenylephrine, also known as mesaton or fenilefrina, belongs to the class of organic compounds known as 1-hydroxy-4-unsubstituted benzenoids. These are phenols that are unsubstituted at the 4-position. Phenylephrine is a very strong basic compound (based on its pKa). Phenylephrine is a bitter tasting compound. Outside of the human body,. It is often used in combination with tropicamide as a synergist when tropicamide alone is not sufficient. |
---|
Structure | CNC[C@H](O)C1=CC(O)=CC=C1 InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol | ChEBI | Fenilefrina | ChEBI | L-(3-Hydroxyphenyl)-N-methylethanolamine | ChEBI | Phenylephrinum | ChEBI | R(-)-Phenylephrine | ChEBI | Phenylephrine minims | Kegg | (-)-m-Hydroxy-a-(methylaminomethyl)benzyl alcohol | Generator | (-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol | Generator | Adrianol | HMDB | Ak-dilate | HMDB | Ak-nefrin | HMDB | Alcon efrin | HMDB | Alconefrin nasal drops 12 | HMDB | Alconefrin nasal drops 25 | HMDB | Alconefrin nasal drops 50 | HMDB | Alconefrin nasal spray 25 | HMDB | Biomydrin | HMDB | Dilatair | HMDB | Dionephrine | HMDB | Doktors | HMDB | Duration | HMDB | I-phrine | HMDB | Isophrim | HMDB | Isophrin | HMDB | Isopto frin | HMDB | m-Methylaminoethanolphenol | HMDB | m-Oxedrine | HMDB | m-Sympathol | HMDB | m-Sympatol | HMDB | m-Synephrine | HMDB | Mesaton | HMDB | Mesatone | HMDB | Mesatonum | HMDB | Metaoxedrin | HMDB | Metaoxedrine | HMDB | Metaoxedrinum | HMDB | Metasympatol | HMDB | Metasynephrine | HMDB | Mezaton | HMDB | Minims phenylephrine | HMDB | Mydfrin | HMDB | Neo-synephrine | HMDB | Neo-synephrine nasal drops | HMDB | Neo-synephrine nasal jelly | HMDB | Neo-synephrine nasal spray | HMDB | Neo-synephrine pediatric nasal drops | HMDB | Neofrin | HMDB | Neophryn | HMDB | Neosynephrine | HMDB | Nostril | HMDB | Nostril spray pump | HMDB | Nostril spray pump mild | HMDB | Ocu-phrin sterile eye drops | HMDB | Ocu-phrin sterile ophthalmic solution | HMDB | Ocugestrin | HMDB | Phenoptic | HMDB | Prefrin | HMDB | Prefrin liquifilm | HMDB | Pyracort D | HMDB | R(-)-Mezaton | HMDB | Relief eye drops for red eyes | HMDB | Rhinall | HMDB | Spersaphrine | HMDB | Vicks sinex | HMDB | Visadron | HMDB | Neo synephrine | HMDB | Phenylephrine tannate | HMDB | Tannate, phenylephrine | HMDB | (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol | HMDB | Phenylephrine hydrochloride | HMDB |
|
---|
Chemical Formula | C9H13NO2 |
---|
Average Molecular Weight | 167.205 |
---|
Monoisotopic Molecular Weight | 167.094628665 |
---|
IUPAC Name | 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol |
---|
Traditional Name | phenylephrine |
---|
CAS Registry Number | 59-42-7 |
---|
SMILES | CNC[C@H](O)C1=CC(O)=CC=C1 |
---|
InChI Identifier | InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1 |
---|
InChI Key | SONNWYBIRXJNDC-VIFPVBQESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1-hydroxy-4-unsubstituted benzenoids. These are phenols that are unsubstituted at the 4-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | 1-hydroxy-4-unsubstituted benzenoids |
---|
Direct Parent | 1-hydroxy-4-unsubstituted benzenoids |
---|
Alternative Parents | |
---|
Substituents | - 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- 1,2-aminoalcohol
- Secondary alcohol
- Secondary aliphatic amine
- Secondary amine
- Alcohol
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Aromatic alcohol
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | -0.31 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Phenylephrine,1TMS,isomer #1 | CNC[C@H](O[Si](C)(C)C)C1=CC=CC(O)=C1 | 1696.2 | Semi standard non polar | 33892256 | Phenylephrine,1TMS,isomer #2 | CNC[C@H](O)C1=CC=CC(O[Si](C)(C)C)=C1 | 1652.2 | Semi standard non polar | 33892256 | Phenylephrine,1TMS,isomer #3 | CN(C[C@H](O)C1=CC=CC(O)=C1)[Si](C)(C)C | 1754.1 | Semi standard non polar | 33892256 | Phenylephrine,2TMS,isomer #1 | CNC[C@H](O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1 | 1640.9 | Semi standard non polar | 33892256 | Phenylephrine,2TMS,isomer #2 | CN(C[C@H](O[Si](C)(C)C)C1=CC=CC(O)=C1)[Si](C)(C)C | 1794.1 | Semi standard non polar | 33892256 | Phenylephrine,2TMS,isomer #3 | CN(C[C@H](O)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1804.2 | Semi standard non polar | 33892256 | Phenylephrine,3TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1805.8 | Semi standard non polar | 33892256 | Phenylephrine,3TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1802.8 | Standard non polar | 33892256 | Phenylephrine,3TMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C)C1=CC=CC(O[Si](C)(C)C)=C1)[Si](C)(C)C | 1815.2 | Standard polar | 33892256 | Phenylephrine,1TBDMS,isomer #1 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O)=C1 | 1908.6 | Semi standard non polar | 33892256 | Phenylephrine,1TBDMS,isomer #2 | CNC[C@H](O)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 1901.7 | Semi standard non polar | 33892256 | Phenylephrine,1TBDMS,isomer #3 | CN(C[C@H](O)C1=CC=CC(O)=C1)[Si](C)(C)C(C)(C)C | 1997.2 | Semi standard non polar | 33892256 | Phenylephrine,2TBDMS,isomer #1 | CNC[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1 | 2111.5 | Semi standard non polar | 33892256 | Phenylephrine,2TBDMS,isomer #2 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O)=C1)[Si](C)(C)C(C)(C)C | 2278.6 | Semi standard non polar | 33892256 | Phenylephrine,2TBDMS,isomer #3 | CN(C[C@H](O)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2287.5 | Semi standard non polar | 33892256 | Phenylephrine,3TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2524.6 | Semi standard non polar | 33892256 | Phenylephrine,3TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2443.0 | Standard non polar | 33892256 | Phenylephrine,3TBDMS,isomer #1 | CN(C[C@H](O[Si](C)(C)C(C)(C)C)C1=CC=CC(O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2205.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Phenylephrine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-014i-0900000000-b11a2a880d1683fa6cae | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylephrine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-01b9-6900000000-bbdd210a846be116dbcd | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylephrine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-b11a2a880d1683fa6cae | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Phenylephrine GC-EI-TOF (Non-derivatized) | splash10-01b9-6900000000-bbdd210a846be116dbcd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylephrine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9200000000-3ea7ffd258ffba5a376a | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylephrine GC-MS (2 TMS) - 70eV, Positive | splash10-014i-4920000000-54a2b2a88914c83610f2 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenylephrine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-0udi-0900000000-d95a741ffcfe3f7bb7e9 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-0006-9800000000-7695881b36499169fb71 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-054o-9200000000-888fce606d860cd39be2 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-014i-0900000000-edfcbc18ccdb6872b791 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-00di-0900000000-15132688bbc7ac0be42f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-00di-2900000000-34ccc7192518d4c14210 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-00di-3900000000-e619f4210f81c11f61be | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-00dl-6900000000-3178337a019ac9bf313d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0gb9-0900000000-e738818606836c1d6d1a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0udi-0900000000-36b72327f64f1355a502 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-052o-4900000000-935a9659fe39602b138d | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-052f-9800000000-7d83555b537d6fec673b | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-054o-9400000000-5ef2f6d1da57087e6ac7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive-QTOF | splash10-014i-0900000000-4a910a2109ba191b96e7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ , negative-QTOF | splash10-014i-0900000000-edfcbc18ccdb6872b791 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ , negative-QTOF | splash10-00di-0900000000-15132688bbc7ac0be42f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ , negative-QTOF | splash10-00di-2900000000-34ccc7192518d4c14210 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ , negative-QTOF | splash10-00di-3900000000-e8a5a4f1aae0796866a7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Phenylephrine LC-ESI-QQ , negative-QTOF | splash10-00dl-6900000000-3178337a019ac9bf313d | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 10V, Positive-QTOF | splash10-0uxr-0900000000-8c4893aa69ea6a1ceecb | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 20V, Positive-QTOF | splash10-0uxr-0900000000-4406afb22d76646e2ef8 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 40V, Positive-QTOF | splash10-01c3-7900000000-56a2a2741d2166bf31bc | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 10V, Negative-QTOF | splash10-014i-0900000000-0cf5a5fa80f87facb9ad | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 20V, Negative-QTOF | splash10-014j-2900000000-687762e0d4bf3efbffec | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenylephrine 40V, Negative-QTOF | splash10-0006-9400000000-140e96de62b4341791d9 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Kamiya A, Kawada T, Yamamoto K, Michikami D, Ariumi H, Miyamoto T, Uemura K, Sugimachi M, Sunagawa K: Muscle sympathetic nerve activity averaged over 1 minute parallels renal and cardiac sympathetic nerve activity in response to a forced baroreceptor pressure change. Circulation. 2005 Jul 19;112(3):384-6. Epub 2005 Jul 5. [PubMed:15998668 ]
- Thebault S, Zholos A, Enfissi A, Slomianny C, Dewailly E, Roudbaraki M, Parys J, Prevarskaya N: Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line. J Cell Physiol. 2005 Jul;204(1):320-8. [PubMed:15672411 ]
- Rios JD, Horikawa Y, Chen LL, Kublin CL, Hodges RR, Dartt DA, Zoukhri D: Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res. 2005 Apr;80(4):477-91. [PubMed:15781275 ]
- Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, Lamy A, Semelhago L, Lee RM: Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg. 2005 Oct;130(4):1130-6. [PubMed:16214530 ]
- Gonzalez-Cadavid NF, Ryndin I, Vernet D, Magee TR, Rajfer J: Presence of NMDA receptor subunits in the male lower urogenital tract. J Androl. 2000 Jul-Aug;21(4):566-78. [PubMed:10901443 ]
- Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G: Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004 Dec;22(12):2363-9. [PubMed:15614031 ]
- Bouchelouche K, Andersen L, Alvarez S, Nordling J, Bouchelouche P: Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. J Urol. 2005 Feb;173(2):657-61. [PubMed:15643283 ]
- Boschmann M, Krupp G, Luft FC, Klaus S, Jordan J: In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue. Obes Res. 2002 Jun;10(6):555-8. [PubMed:12055332 ]
- Chueh SC, Chern JW, Choong CM, Guh JH, Teng CM: Characterization of some novel alpha 1-adrenoceptor antagonists in human hyperplastic prostate. Eur J Pharmacol. 2002 Jun 7;445(1-2):125-31. [PubMed:12065203 ]
- Wang SY, Song Y, Xu M, Hao TP, Han QD, Zhang YY: [Redistribution of three alpha1-adrenergic receptor subtypes in the stably transfected HEK 293A cells upon agonist stimulation.]. Sheng Li Xue Bao. 2005 Aug 25;57(4):480-5. [PubMed:16094496 ]
- Guh JH, Hsieh CH, Teng CM: Investigation of the effects of some alkaloidal alpha1-adrenoceptor antagonists on human hyperplastic prostate. Eur J Pharmacol. 1999 Jun 25;374(3):503-10. [PubMed:10422796 ]
- Nomiya M, Yamaguchi O: A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol. 2003 Aug;170(2 Pt 1):649-53. [PubMed:12853849 ]
- Lam KY, Yuen AP: Cancer of the larynx in Hong Kong: a clinico-pathological study. Eur J Surg Oncol. 1996 Apr;22(2):166-70. [PubMed:8608835 ]
|
---|